Table 3.
The prevalence % (CI) of different comorbidities in normal, pre-diabetes, and undiagnosed and diagnosed diabetes, community-based cohort study (KERCADR−2nd Phase-N = 9,959), Kerman, Iran, 2014–2018.
| Comorbidities (PHASE2) | Normal | Pre-DM | Undiagnosed DM | Diagnosed DM |
|---|---|---|---|---|
| Hypertension | 22.1 (21.2–23.1) | 35.6 (33.1–38.1) | 44.7 (38.9–50.5) | 61.0 (58.4–63.6) |
| Hypercholesterolemia | 14.1 (13.3–15.0) | 26.6 (24.3–28.9) | 40.5 (34.8–46.2) | 55.4 (52.8–58.1) |
| Hypertriglyceridemia | 30.3 (29.2–31.3) | 46.0 (43.4–48.6) | 61.8 (56.2–67.5) | 70.3 (67.9–72.7) |
| Depression | 15.9 (15.0–16.7) | 13.7 (11.9–15.5) | 10.1 (6.6–13.6) | 20.4 (18.3–22.6) |
| Anxiety | 40.6 (39.4–41.7) | 39.2 (36.6–41.7) | 35.6 (30.1–41.2) | 46.1 (43.4–48.7) |
| Overweight and obesity | 59.4 (58.2–60.5) | 75.9 (73.6–78.1) | 83.5 (79.2–87.8) | 77.3 (75.1–79.5) |
CI, confidence interval; DM, diabetes mellitus; pre-DM, pre-diabetes.